Craig Lumb

Craig is a solicitor in the Dispute Resolution team with a focus on patent litigation, primarily in the life sciences sector. He has experience of litigation in the High Court and the Court of Appeal in the UK and of coordinating parallel litigation across multiple jurisdictions in the context of global pharmaceutical life cycle management projects. Craig’s experience includes advising on disputes concerning formulation, process, second medical use and dosage regimen patents in the fields of small molecule pharmaceuticals, non-biological complex drugs, and therapeutic antibodies. Craig has also advised clients on SPC issues.

Craig was ranked as a “Leading Associate” in the “Intellectual property: patents (contentious and non-contentious)” category in both the 2025 and 2026 editions of the Legal 500 UK Guide, and as a “Rising Star” in the IP Stars 2025 Guide by Managing IP.

Outside of the life sciences sector Craig has worked on telecoms disputes involving SEP litigation and FRAND issues. On the non-contentious side, Craig has previously assisted clients with the IP aspects of M&A transactions and licensing agreements. He also has in-house experience, having spent six months on secondment to the group legal department of an international defence, aerospace and security company where he was involved with a wide range of corporate and commercial matters.

Before joining Carpmaels & Ransford in 2018, Craig trained at a global firm and worked at one of London’s leading IP firms post-qualification. Craig has a degree in Natural Sciences, specialising in Chemistry, from the University of Cambridge and a doctorate in Biochemistry from the University of Oxford.